Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
Retrophin's peak revenue was $198.3M in 2020. The peak quarterly revenue was $54.2M in 2022(q2).
Retrophin's revenue increased from $99.9m in 2014 to $198.3M currently. That's a 603.19% change in annual revenue.
| Fiscal year / year | Retrophin revenue |
|---|---|
| 2014 | $28.2M |
| 2015 | $99.9M |
| 2016 | $133.6M |
| 2017 | $154.9M |
| 2018 | $164.2M |
| 2019 | $175.3M |
| 2020 | $198.3M |
How accurately did Retrophin's revenue projections match actual performance?
Retrophin saw the greatest revenue growth in 2016, when revenue increased by 33.74%.
Retrophin had the lowest revenue growth in 2022, when revenue changed by -6.8%.
| Year | Retrophin growth |
|---|---|
| 2015 | 254%↑ |
| 2016 | 34%↑ |
| 2017 | 16%↑ |
| 2018 | 6%↑ |
| 2019 | 7%↑ |
| 2020 | 13%↑ |
Do you work at Retrophin?
Is Retrophin transparent about its revenue structure?
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 262 |
| Date Founded | 2011 |
| Headquarters | San Diego, California |
| Number of Locations | 1 |
| Revenue | $198.3M |
| Net Income | -$278,482,000 |
| Gross Proft | $192.2M (2020) |
| Tax Rate | 0.1% |
| Total Assets | $672,585,000 |
| Ticker | TVTX |
Retrophin received early financing of $25.0M on 2013-08-16.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Equity | $25M | 08/2013 |
| Post Ipo Equity | $46M | 05/2014 |
| Post Ipo Debt | $45M | 07/2014 |
| Post Ipo Equity | $201.5M | 02/2021 |
| Post Ipo Debt | $275M | 03/2022 |
| Investors | Security type |
|---|---|
| Athyrium Capital Management LP | Post Ipo Equity |
| Athyrium Capital Management LP | Post Ipo Debt |
Zippia gives an in-depth look into the details of Retrophin, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Retrophin. The employee data is based on information from people who have self-reported their past or current employments at Retrophin. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Retrophin. The data presented on this page does not represent the view of Retrophin and its employees or that of Zippia.
Retrophin may also be known as or be related to RETROPHIN INC, Retrophin, Retrophin Inc, Retrophin, Inc. and Travere Therapeutics Inc.